Category Archives: Advertising

ePharma Summit: Turning Big Data into Better Content

By Ben Comer | Published: March 6, 2013

Physicians and patients are more intimately engaged with their digital devices than ever before, but the content pharma delivers is either rigidly scientific or numbingly bland. Can stronger analytical processes and more data produce a scalable human voice for individual customers?

Also posted in E-Media, Events, FDA, Marketing, Patient Communication, Regulatory, Sales, Strategy, Technology, healthcare, multimedia, social media | Tagged digital marketing, ePharma Summit, patient education, patient engagement, Professional Marketing | Leave a comment

Tom Abrams: Caronia Won't Stop Off-Label Enforcement

By Jill Wechsler | Published: January 30, 2013

The much-discussed US v. Caronia case, which has raised questions about the Food and Drug Administration prosecution of pharma companies for making off-label product claims, doesn’t change very much, according to FDA’s top drug marketing enforcer.

Also posted in Agency Insight, E-Media, FDA, Legal, Marketing, Regulatory, leadership, social media | Tagged CBI, FDA, First Amendment, misbranding, off-label, OPDP, Tom Abrams, US v. Caronia | 1 Comment

Pharma's Promotional Spend: What's the Right Target?

By Clark Herman | Published: January 17, 2013

Global consultancy Cegedim has released its latest survey on how and where big Pharma puts its promotional dollar. Pharmaceutical Promotional Spend: Global Trends reports that spending in emerging markets significantly increased last year, while Europe and US declined slightly. Although overall promotion spending remained flat worldwide at $90 billion, the US still accounts for the [...]

Also posted in Emerging Markets, Europe, Global, Marketing, Meetings, Sales, Strategy, Technology, social media | Tagged Detailing, digital, Global, Promotion, sales representatives, trends | Leave a comment

Oncologists, in Detail

By Ben Comer | Published: January 11, 2013

On average, cancer docs in the US would much rather deal with pharma sales reps in person as opposed to online, and drug companies are hiring more reps to support a slew of newly approved oncologic drugs, even as reps in other therapeutic areas get pink slips. But external pressures are likely to further limit [...]

Also posted in Sales, healthcare, social media | Tagged Oncology, physicians, professional sales, sales rep | Leave a comment

US v. Caronia: What Constitutes 'Truthful' Speech?

By Ben Comer | Published: December 5, 2012

If a drug’s label is not the final word on what is true – or untrue – about a product, then who decides what can and cannot be said during a sales detail?

Also posted in FDA, Legal, Marketing, Regulatory, Safety, Sales, Strategy, compliance | Tagged Alfred Caronia, Appeals Court, Detailing, DoJ, FDA, Federal Trade Commission, FTC, Jazz Pharmaceuticals, Marketing, off-label, Office of Prescription Drug Promotion, Orphan Medical, OTC, Professional Marketing, Promotion, Regulatory, sales rep, Sorrell v. IMS Health, US v. Caronia | 1 Comment